Andre Jacques Auberton Herve - Jun 13, 2023 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role: Director
Signature: /s/ Andre-Jacques Auberton-Herve
Stock symbol: BNKL
Transactions as of: Jun 13, 2023
Transactions value $: $331,667
Form type: 4
Date filed: 6/21/2023, 10:58 AM
Previous filing: Jun 21, 2023
Next filing: Dec 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNKL	Common Stock	Conversion of derivative security	$112K	+186K	+20.16%	$0.60	1.11M	Jun 13, 2023	Shares held through Star SCI	F1
holding	BNKL	Common Stock						10.7K	Jun 13, 2023	Shares held through 4A Consulting and Engineering
holding	BNKL	Common Stock						95.1K	Jun 13, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNKL	Convertible Promissory Note	Purchase	$220K	+1		$220,000.00^*	1	Jun 13, 2023	Common Stock, par value $0.001 per share	367K	$0.60	Through Star SCI	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Effective as of June 13, 2023, approximately $310,185 of principal and accrued interest of a convertible promissory note issued to Star SCI, an affiliate of the reporting person, converted in accordance with its terms into 186,111 shares of the Issuer's common stock
F2	The convertible promissory note (the "Note") will be convertible into common stock of the Issuer upon the following events on the following terms: (a) on June 1, 2024 without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to $0.60 per share; and (b) upon the consummation of the next equity or equity linked round of financing of the Issuer for cash proceeds (the "Qualified Financing"), without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to the lesser of (a) the issue price per share in the Qualified Financing and (b) $0.60 per share.

Content

Effective as of June 13, 2023, approximately $310,185 of principal and accrued interest of a convertible promissory note issued to Star SCI, an affiliate of the reporting person, converted in accordance with its terms into 186,111 shares of the Issuer's common stock

The convertible promissory note (the "Note") will be convertible into common stock of the Issuer upon the following events on the following terms: (a) on June 1, 2024 without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to $0.60 per share; and (b) upon the consummation of the next equity or equity linked round of financing of the Issuer for cash proceeds (the "Qualified Financing"), without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to the lesser of (a) the issue price per share in the Qualified Financing and (b) $0.60 per share.